PDT Partners’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-605
| Closed | -$148K | – | 884 |
|
|
2020
Q3 | $148K | Buy |
+605
| New | +$148K | 0.01% | 661 |
|
|
2019
Q1 | – | Sell |
-427
| Closed | -$130K | – | 512 |
|
|
2018
Q4 | $130K | Buy |
427
+74
| +21% | +$22.5K | 0.01% | 431 |
|
|
2018
Q3 | $127K | Sell |
353
-848
| -71% | -$305K | 0.01% | 453 |
|
|
2018
Q2 | $439K | Buy |
1,201
+451
| +60% | +$165K | 0.02% | 411 |
|
|
2018
Q1 | $222K | Buy |
+750
| New | +$222K | 0.01% | 515 |
|
|
2015
Q2 | – | Sell |
-44
| Closed | -$373K | – | 1699 |
|
|
2015
Q1 | $373K | Buy |
+44
| New | +$373K | 0.01% | 1108 |
|